{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:21:23Z","timestamp":1791901283764,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"FUNDING The study was funded by Zhengzhou Science and Technology Bureau","award":["2024ZZJCYJ048"],"award-info":[{"award-number":["2024ZZJCYJ048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03491-6","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T15:23:01Z","timestamp":1765898581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TXNIP regulates the proliferation of scar fibroblasts through oxidative stress"],"prefix":"10.1186","volume":"30","author":[{"given":"Wenbo","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"5","key":"3491_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/wound.2021.0028","volume":"11","author":"AD Menchaca","year":"2022","unstructured":"Menchaca AD, Style CC, Olutoye OO. A review of hypertrophic scar and keloid treatment and prevention in the pediatric population: Where are we now? Adv Wound Care. 2022;11(5):255\u201379.","journal-title":"Adv Wound Care"},{"issue":"8","key":"3491_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/biom11081165","volume":"11","author":"M Waasdorp","year":"2021","unstructured":"Waasdorp M, Krom BP, Bikker FJ, van Zuijlen PPM, Niessen FB, Gibbs S. The bigger picture: why oral mucosa heals better than skin. Biomolecules. 2021;11(8):1165.","journal-title":"Biomolecules"},{"issue":"4","key":"3491_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/wound.2021.0060","volume":"11","author":"L Schaffrick","year":"2022","unstructured":"Schaffrick L, Ding J, Kwan P, Tredget EE. Molecular features of hypertrophic scars after thermal injury: Is there a biologic basis for laser therapy? Adv Wound Care. 2022;11(4):163\u201378.","journal-title":"Adv Wound Care"},{"issue":"1","key":"3491_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13287-024-03749-6","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang M, Zhao J, Li J, Meng M, Zhu M. Insights into the role of adipose-derived stem cells and secretome: potential biology and clinical applications in hypertrophic scarring. Stem Cell Res Ther. 2024;15(1):137.","journal-title":"Stem Cell Res Ther"},{"issue":"31","key":"3491_CR5","doi-asserted-by":"publisher","first-page":"21645","DOI":"10.1074\/jbc.274.31.21645","volume":"274","author":"A Nishiyama","year":"1999","unstructured":"Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2\/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem. 1999;274(31):21645\u201350.","journal-title":"J Biol Chem"},{"issue":"1","key":"3491_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCRESAHA.122.321538","volume":"132","author":"SH Woo","year":"2023","unstructured":"Woo SH, Kyung D, Lee SH, et al. TXNIP suppresses the osteochondrogenic switch of vascular smooth muscle cells in atherosclerosis. Circ Res. 2023;132(1):52\u201371.","journal-title":"Circ Res"},{"key":"3491_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","volume":"66","author":"J Lu","year":"2014","unstructured":"Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med. 2014;66:75\u201387.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"3491_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/CIRCRESAHA.122.321351","volume":"131","author":"Y Nakayama","year":"2022","unstructured":"Nakayama Y, Mukai N, Kreitzer G, Patwari P, Yoshioka J. Interaction of ARRDC4 with GLUT1 mediates metabolic stress in the ischemic heart. Circ Res. 2022;131(6):510\u201327.","journal-title":"Circ Res"},{"key":"3491_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102735","volume":"63","author":"J Kim","year":"2023","unstructured":"Kim J, Lim J, Yoo ID, Park S, Moon JS. TXNIP contributes to induction of pro-inflammatory phenotype and caspase-3 activation in astrocytes during Alzheimer\u2019s diseases. Redox Biol. 2023;63:102735.","journal-title":"Redox Biol"},{"issue":"1","key":"3491_CR10","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1038\/s41467-024-46328-2","volume":"15","author":"ZR Yang","year":"2024","unstructured":"Yang ZR, Suo H, Fan JW, et al. Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment. Nat Commun. 2024;15(1):2038.","journal-title":"Nat Commun"},{"issue":"5","key":"3491_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/pcmr.12780","volume":"32","author":"A Alkhalil","year":"2019","unstructured":"Alkhalil A, Carney BC, Travis TE, et al. Dyspigmented hypertrophic scars: beyond skin color. Pigment Cell Melanoma Res. 2019;32(5):643\u201356.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"3491_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166887","volume":"1870","author":"Y Dong","year":"2024","unstructured":"Dong Y, Cao X, Huang J, et al. Melatonin inhibits fibroblast cell functions and hypertrophic scar formation by enhancing autophagy through the MT2 receptor-inhibited PI3K\/Akt\/mTOR signaling. Biochimica et Biophysica Acta (BBA). 2024;1870(1):166887.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"3491_CR13","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.3892\/mmr.2020.11539","volume":"22","author":"L Jiang","year":"2020","unstructured":"Jiang L, Deng Y, Li W, Lu Y. Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress. Mol Med Rep. 2020;22(6):4783\u201391.","journal-title":"Mol Med Rep"},{"issue":"1","key":"3491_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/wound.2020.1348","volume":"12","author":"B Yuan","year":"2023","unstructured":"Yuan B, Upton Z, Leavesley D, Fan C, Wang XQ. Vascular and collagen target: a rational approach to hypertrophic scar management. Adv Wound Care. 2023;12(1):38\u201355.","journal-title":"Adv Wound Care"},{"key":"3491_CR15","doi-asserted-by":"crossref","unstructured":"Domingues A, Jolibois J, Marquet de Roug\u00e9 P, Nivet-Antoine V. The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target. Int J Mol Sci. 2021;22(4):1693.","DOI":"10.3390\/ijms22041693"},{"issue":"24","key":"3491_CR16","doi-asserted-by":"publisher","first-page":"9357","DOI":"10.3390\/ijms21249357","volume":"21","author":"H Tsubaki","year":"2020","unstructured":"Tsubaki H, Tooyama I, Walker DG. Thioredoxin-interacting protein (TXNIP) with focus on brain and neurodegenerative diseases. Int J Mol Sci. 2020;21(24):9357.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3491_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10787-021-00861-4","volume":"29","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hu G, Shao N, et al. Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer\u2019s disease: flavonoids and phenols. Inflammopharmacology. 2021;29(5):1317\u201329.","journal-title":"Inflammopharmacology"},{"issue":"9","key":"3491_CR18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41374-018-0078-8","volume":"98","author":"M Wu","year":"2018","unstructured":"Wu M, Li R, Hou Y, et al. Thioredoxin-interacting protein deficiency ameliorates kidney inflammation and fibrosis in mice with unilateral ureteral obstruction. Lab Invest. 2018;98(9):1211\u201324.","journal-title":"Lab Invest"},{"issue":"38","key":"3491_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq1799","volume":"8","author":"F Liu","year":"2022","unstructured":"Liu F, Cai Z, Yang Y, et al. The adipocyte-enriched secretory protein tetranectin exacerbates type 2 diabetes by inhibiting insulin secretion from \u03b2 cells. Sci Adv. 2022;8(38):eabq1799.","journal-title":"Sci Adv"},{"key":"3491_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.freeradbiomed.2017.06.016","volume":"110","author":"D Tian","year":"2017","unstructured":"Tian D, Dong J, Jin S, Teng X, Wu Y. Endogenous hydrogen sulfide-mediated MAPK inhibition preserves endothelial function through TXNIP signaling. Free Radic Biol Med. 2017;110:291\u20139.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"3491_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2174\/1389450111009011571","volume":"11","author":"FA Wagener","year":"2010","unstructured":"Wagener FA, Scharstuhl A, Tyrrell RM, et al. The heme\u2013heme oxygenase system in wound healing; implications for scar formation. Curr Drug Targets. 2010;11(12):1571\u201385.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"3491_CR22","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1007\/s12035-021-02320-1","volume":"58","author":"L Bai","year":"2021","unstructured":"Bai L, Yan F, Deng R, Gu R, Zhang X, Bai J. Thioredoxin-1 rescues MPP(+)\/MPTP-induced ferroptosis by increasing glutathione peroxidase 4. Mol Neurobiol. 2021;58(7):3187\u201397.","journal-title":"Mol Neurobiol"},{"key":"3491_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2017.04.005","volume":"47","author":"M Idelchik","year":"2017","unstructured":"Idelchik M, Begley U, Begley TJ, Melendez JA. Mitochondrial ROS control of cancer. Semin Cancer Biol. 2017;47:57\u201366.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"3491_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/ars.2012.4822","volume":"18","author":"TC Zschauer","year":"2013","unstructured":"Zschauer TC, Matsushima S, Altschmied J, Shao D, Sadoshima J, Haendeler J. Interacting with thioredoxin-1\u2013disease or no disease? Antioxid Redox Signal. 2013;18(9):1053\u201362.","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"3491_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-019-2035-x","volume":"10","author":"C Wen","year":"2019","unstructured":"Wen C, Wang H, Wu X, et al. ROS-mediated inactivation of the PI3K\/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death Dis. 2019;10(11):809.","journal-title":"Cell Death Dis"},{"key":"3491_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2016.12.020","volume":"109","author":"N Nagarajan","year":"2017","unstructured":"Nagarajan N, Oka S, Sadoshima J. Modulation of signaling mechanisms in the heart by thioredoxin 1. Free Radic Biol Med. 2017;109:125\u201331.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"3491_CR27","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1007\/s12035-019-1489-2","volume":"56","author":"A Islam","year":"2019","unstructured":"Islam A, Kagawa Y, Miyazaki H, et al. FABP7 protects astrocytes against ROS toxicity via lipid droplet formation. Mol Neurobiol. 2019;56(8):5763\u201379.","journal-title":"Mol Neurobiol"},{"key":"3491_CR28","doi-asserted-by":"publisher","first-page":"22759","DOI":"10.1038\/srep22759","volume":"6","author":"QR Bi","year":"2016","unstructured":"Bi QR, Hou JJ, Qi P, et al. TXNIP\/TRX\/NF-\u03baB and MAPK\/NF-\u03baB pathways involved in the cardiotoxicity induced by Venenum Bufonis in rats. Sci Rep. 2016;6:22759.","journal-title":"Sci Rep"},{"issue":"5","key":"3491_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1089\/wound.2021.0161","volume":"12","author":"YK Hong","year":"2023","unstructured":"Hong YK, Chang YH, Lin YC, Chen B, Guevara BEK, Hsu CK. Inflammation in wound healing and pathological scarring. Adv Wound Care. 2023;12(5):288\u2013300.","journal-title":"Adv Wound Care"},{"key":"3491_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603187","volume":"11","author":"ZC Wang","year":"2020","unstructured":"Wang ZC, Zhao WY, Cao Y, et al. The roles of inflammation in keloid and hypertrophic scars. Front Immunol. 2020;11:603187.","journal-title":"Front Immunol"},{"issue":"4","key":"3491_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101079","volume":"11","author":"M Shao","year":"2024","unstructured":"Shao M, Pan Q, Tan H, et al. CYP3A5 unexpectedly regulates glucose metabolism through the AKT-TXNIP-GLUT1 axis in pancreatic cancer. Genes Dis. 2024;11(4):101079.","journal-title":"Genes Dis"},{"issue":"7","key":"3491_CR32","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"EH Choi","year":"2023","unstructured":"Choi EH, Park SJ. TXNIP: a key protein in the cellular stress response pathway and a potential therapeutic target. Exp Mol Med. 2023;55(7):1348\u201356.","journal-title":"Exp Mol Med"},{"issue":"11","key":"3491_CR33","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.3390\/ijms22116107","volume":"22","author":"N Inui","year":"2021","unstructured":"Inui N, Sakai S, Kitagawa M. Molecular pathogenesis of pulmonary fibrosis, with focus on pathways related to TGF-\u03b2 and the ubiquitin-proteasome pathway. Int J Mol Sci. 2021;22(11):6107.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3491_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12967-024-05228-1","volume":"22","author":"N Liu","year":"2024","unstructured":"Liu N, Fan X, Shao Y, et al. Resveratrol attenuates inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease via the AKT\/TMEM175 pathway. J Transl Med. 2024;22(1):457.","journal-title":"J Transl Med"},{"key":"3491_CR35","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17551","volume":"12","author":"L Yang","year":"2024","unstructured":"Yang L, Li X, Wang Y. Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis. PeerJ. 2024;12:e17551.","journal-title":"PeerJ"},{"issue":"1","key":"3491_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13643-023-02192-7","volume":"12","author":"LA Walsh","year":"2023","unstructured":"Walsh LA, Wu E, Pontes D, et al. Keloid treatments: an evidence-based systematic review of recent advances. Syst Rev. 2023;12(1):42.","journal-title":"Syst Rev"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03491-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03491-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03491-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T03:01:43Z","timestamp":1765940503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03491-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3491"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03491-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was approved by the Ethics Committee of Zhengzhou University in accordance with ethical guidelines for animal research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This is not available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1240"}}